KIRO Oncology logo

KIRO Oncology

KIRO Oncology is Kiro Grifols' two-arm robotic system for compounding sterile preparations of hazardous drugs, part of the inclusiv IV compounding portfolio.1,2

Robotics Reviewed Editorial TeamUpdated November 10, 2026kirogrifols.com

Our take

KIRO Oncology uses two robotic arms, cameras, barcode readers, and scales to prepare hazardous drug doses in syringes, IV bags, cassettes, and elastomeric pumps inside an enclosed, self-cleaning ISO 5 chamber.1,2

It suits hospital oncology pharmacies that want gravimetric checks at every step. Prices are not published.1

Scores by criterion

KIRO Oncology scores out of 10
Pricing transparency2.5
Product maturity8.0
Deployment evidence6.5
Company durability9.0
Ease of integration7.5
Overall score (average of the five)6.7

Pricing transparency, 2.5: Kiro Grifols publishes no prices and sends buyers to a contact form.1

Product maturity, 8.0: The system has a 12-position vial carousel, a bay for up to 8 final containers, a syringe holder for up to 8 syringes, and two peristaltic pumps for diluent filling and reconstitution.1

Deployment evidence, 6.5: Kiro Grifols sells KIRO Oncology alongside KIRO Fill and Gri-fill 4 as part of its inclusiv portfolio, but its site names few hospital sites.2

Company durability, 9.0: Kiro Grifols belongs to Grifols, a listed healthcare group with revenue of 7,524 million euros in 2025.2,3

Ease of integration, 7.5: KIRO Oncology offers a hospital information system interface, multi-device integration, and compatibility with closed system transfer devices.2

Each criterion is defined on our methodology page.

Who uses KIRO Oncology and what it's for

The buyer is a hospital oncology pharmacy that compounds patient-specific hazardous doses and small batches and wants enclosed, self-cleaning automation.1

KIRO Oncology

Self-cleaning and waste disposal run inside the enclosed chamber under negative pressure, with HEPA exhaust filtration and 30% or 100% exhaust options.1

Pricing

Kiro Grifols sells by quote and does not list prices.1

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprisesNot yet reviewed45678910Review Score← Smaller operationsLarge enterprises →Who it's built for6.76.46.16.7
KIRO Oncology and its competitors
CompanyProductPricing modelDeployment footprintWhere KIRO Oncology wins or loses
KIRO OncologyTwo-arm hazardous drug compounder with gravimetric checks1Not published; quote1Part of the inclusiv IV compounding portfolio2Two-arm hazardous compounder; quote only; Grifols
ARxIUMRIVA IV robot plus packagers, cabinets, and inventory software4Not published; consultation12More than 19 million RIVA doses5ARxIUM wins on one vendor for IV robots and wider pharmacy automation. KIRO Oncology wins on gravimetric checks and self-cleaning.
EQUASHIELD ProAutomated hazardous drug compounder using closed transfer devices7Not published; quote7Equashield sells on five continents8EQUASHIELD Pro wins on closed transfer protection from start to finish. KIRO Oncology wins on gravimetric checks and self-cleaning.
OmnicellIVX Station robot inside the IV Compounding Service10Not published; service model10Hospitals, clinics, and care settings9Omnicell wins on a managed IV compounding service. KIRO Oncology wins on gravimetric checks and self-cleaning.
Loccioni APOTECAchemoAPOTECAchemo IV chemotherapy compounding robot11Not published11User community across the US, Europe, the Gulf, and Asia11Loccioni wins on an established chemo compounding user community. KIRO Oncology wins on gravimetric checks and self-cleaning.

Limits

No published prices.1

Few named hospital deployments on its site.2

Built for hazardous drugs; non-hazardous batches go to KIRO Fill.2

What customers say

Where it helps

Gravimetric checks and camera identification at every step.1

Where it falls short

Quote-only pricing.1

Company backing

Kiro Grifols is part of Grifols, a listed healthcare group with 7,524 million euros of 2025 revenue, so this page is scoped to its KIRO Oncology robot.2,3

    Sources